ZARR

News and price dashboard

Swept 16:56
Sources
27, all reachable
Items
104188
Flagged
12673
Last swept
16:56

STOCKS

121

OPTIONS

25

COMING UP

US majors and your names' earnings, next 7 days

Full calendar

Everything else — unscored, browse only, never pushed

Brief

Oil slide and the Iran headlines driving it

The loudest thing in the feed is crude. Market panels carried inside several of the Investing.com pages show Brent futures at 108.85, down 4.04%, and WTI at 99.71, down 4.24%, with the site's own lead story headlined "FTSE 100 today: Stocks extends slide as oil sinks on hopes of U.S.-Iran talks" and a companion piece on sterling gaining as the dollar slips on Iran diplomacy bets. The same panels show the S&P 500 at 7,580.07, down 1.82%, the Dow down 1.09% at 51,770, the FTSE 100 at 10,702.71, down 0.25%, gold futures up 0.58% at 3,921 and silver up 2.14% at 50.33. Around that, headline-only wires fill in the geopolitics: Iran's IRGC reports an oil tanker struck a naval mine and caught fire in the eastern Strait of Hormuz; separately, Iranian officials have left Doha after indirect talks with Washington while a draft proposal circulates, with Tehran insisting the US naval blockade ends before any final deal. Vitol's CEO is quoted across several headline items saying a correction "could be quite severe" if the US and Iran reach an agreement, that by end-2026 demand will have shrunk by roughly 3 million barrels a day, that it would take a full year for demand to recover to 2025 levels, and that the world cannot cope with a larger disruption than today's. ADNOC's chief says the world has "eroded its supply buffers." All of those are headline-level only, so I can't give you the reasoning behind them beyond what's quoted.

Marvell-Lumentum and the chip backdrop

Two headline items flag Marvell agreeing a $115 billion all-stock deal for Lumentum, framed by Investor's Business Daily as creating an AI connectivity leader. The detail behind the deal isn't in anything I read in full, but a Marvell Form 8K page I did read carries the ticker line MRVL at -10.05%, so the market reaction on Marvell's side was sharply negative on the day. A TradingView headline on LITE notes it testing mid-channel support. Separately, IBD headlines say Check Point fell on a Q3 revenue and billings miss, and NAPCO Security stock tumbled 20% after a fiscal Q1 revenue miss.

KeyBanc cuts three space and defense targets for the same reason

Three notes I read in full, all published within minutes of each other, all cut targets while keeping Overweight ratings, and all cite the same cause: broader sector multiple compression from near-term award timing, the midterm election overhang, and rising rates. Firefly Aerospace goes to $35 from $50, with the shares at $17.93 and down 47% over six months; the note says Alpha Flights 8 and 9 are targeted for Q4 2026 with Flight 9 contingent on Flight 8, most of the 2027 manifest is sold, six lunar missions are awarded including the $144 million Blue Ghost and $75 million MoonFall contracts, and roughly $940 million of liquidity sat on the balance sheet at the end of Q2 2026, so KeyBanc doesn't expect a near-term raise. Intuitive Machines goes to $30 from $38, shares at $10.67 and down 58% over six months, with six awarded missions, Altus-1 launching with IM-3 in Q1 2027 and the remaining four satellites in 2028; the firm frames the Navigation and Space Network Services segment as a bridge from milestone revenue to recurring service revenue. Both notes point to NASA's next Commercial Lunar Payload Services award expected 7 November. AeroVironment goes to $200 from $220, shares at $126.11 after a 66% fall over the past year, with the $465 million Army E-HEL award and LOCUST's first international order cited as strengthening the longer-term counter-UAS case; KeyBanc expects limited FY27 contribution from newer platforms and is watching P550 conversion, Switchblade delivery timing, SCDE backlog and the Salt Lake City capacity expansion, with consensus at $3.24 EPS for FY27 after a trailing loss of $4.07.

SBI Holdings H1 beat

SBI reported H1 FY2026 EPS of 127.63 against a 101.01 forecast, about 26.4% ahead. Revenue was JPY 1,057.5 billion, up 17.2%; pretax profit JPY 324.3 billion, up 52.9%; profit for the period JPY 249.1 billion, up 52.6%; profit attributable to owners JPY 230.6 billion, up 39.1%, with annualised ROE of 23.2%. Financial services did the work, with segment pretax profit above JPY 200 billion for the first time, up 69.7%. SBI SECURITIES passed 17 million Japanese accounts, assets under custody rose 39% to JPY 79 trillion and the investment trust balance rose 49.5% to JPY 32.3 trillion. The dividend was lifted to JPY 80 at year-end, JPY 110 annual. Despite that, the stock was down 1.67% at 2,818.5, roughly 27% off its 52-week high; the write-up attributes the muted reaction to caution over valuation and the sheer spread of projects — digital assets, stablecoins, AI, media, Vietnam expansion, a JPY 50 trillion AUM target by 2030 — rather than anything specific in the numbers.

PCBL Chemical: less volume, better margin

PCBL's Q2 FY2027 showed revenue up 14% to INR 2,474 crore, EBITDA up 12% to INR 310 crore and PAT up 20% to INR 74 crore, with the shares up 2.04% at 282.6. Export carbon black volume fell 18% quarter on quarter, which management said was deliberate — they walked away from low-margin business in Southeast Asia and other spot markets. EBITDA per tonne was about INR 19,800, or INR 17,500 stripping out a INR 2,300 per tonne benefit from a full INR 33 crore US tariff refund. MD Nilesh Gandhi said the 7% volume growth target for FY2027 now looks "a little bit challenging" given raw material availability and competition, while sticking to double-digit growth in average EBITDA per tonne. Project Alchemy is targeting INR 200-250 crore of savings but delivered only INR 10-15 crore in the quarter, with the bulk expected from Q4 FY2027. Aquapharm contributed INR 433 crore revenue and INR 42 crore EBITDA.

United Foodbrands: 41% growth, stock down 5%

Q2 FY27 consolidated revenue rose 40.9% year on year to INR 429 crore with same-store sales up 24.5%, dine-in transaction volume up 56% and delivery up 47%. Growth was entirely volume-led — no price increases in four quarters — which also meant average bill realisation came under pressure as the cheaper Big Buffet format expanded. Mature-store restaurant operating margin was 14.7%, new-store margin 7.4%, gross margin 65.5% and down 30bp sequentially. The store count ended at 274 with a target of 300-plus by FY27-end and a raised FY2030 target of 425-450. The stock fell 5% to 603.3; the article points to the sequential gross margin dip, higher corporate costs and lower bill realisation as the likely reasons.

A thick cluster of analyst target changes, headlines only

Beyond the KeyBanc notes, the feed carries dozens of one-line broker items, most duplicated across Investing.com's UK and news feeds. AbbVie alone draws three separate raises — Bernstein to $275 on pipeline strength, RBC Capital on immunology growth, and Canaccord on pipeline progress. Other raises named: Bernstein on nVent Electric (strong demand), Gilead (strong growth) and Capri to $24 (margin beat); RBC on General Dynamics (submarine strength) and AstraZeneca (strong results); Keefe Bruyette on CBOE (derivatives), First Business Financial and Amerant Bancorp; Guggenheim on Starbucks (strong sales); Piper Sandler on Mid-America Apartment, PBF Energy and Blue Owl. Cuts: Bernstein SocGen on Qualcomm over handset concerns, Keefe Bruyette on Burke & Herbert, and HSBC on Beiersdorf citing slowing Nivea sales and limited margin upside. Evercore ISI upgraded Mohawk Industries to Outperform, D.A. Davidson upgraded Franklin Electric, Stifel reiterated Buy on Repligen at $207, StoneX reiterated Buy on Shopify ahead of earnings and on Qualcomm ahead of results, and Morgan Stanley named CaixaBank a top pick on an expected net interest income rebound. Nasdaq's consensus-target screens add mechanical moves: Freddie Mac preferred down 39.14% to $13.11, Fannie Mae down 22.93% to $6.71, Theriva up 60% to $4.08, West Pharmaceutical up 12.52% to $467.89, among others. None of these carry reasoning beyond the headline.

Everything else is filings and chart posts

The bulk of the remaining feed is regulatory boilerplate — ten Form 8K and Form 4 pages that I read in full and which contain no content whatsoever beyond the filing title and the site's standard market furniture. The only information in them is the ticker move printed on each page: NRX Pharmaceuticals -14.66%, Strive -10.90%, Valion Bio -10.86%, Marvell -10.05%, Veeco -9.18%, FTAI Aviation -4.46%, PROG Holdings +3.79%, Choice Hotels -1.60%, Intrusion -1.69%, Xeris -0.37%, Meta -1.53%. What the filings actually say is not disclosed in any of them. Alongside that sit roughly fifty TradingView chart-opinion posts on gold, Nasdaq, Bitcoin, XRP, Solana, BNB, TRON and crude, which are individual traders' technical views and carry no reported facts. A handful of smaller corporate headlines round it out: Ingersoll Rand acquiring IVEK, Theriva selling its antibiotic-degrading enzyme portfolio to Biossil, Rectitude acquiring Mr. Butler, UroGen dosing its first UGN-501 patient, Enlivex posting positive 12-month knee osteoarthritis data, Syntec Optics citing a 25% increase in space reconnaissance orders, Intrusion completing a $4 million debt-for-equity exchange, Landstar's CEO buying $714,619 of stock, and Blackstone-led investors buying into LNG Canada for $3.1 billion. Strategy's Saylor posted the purchase of 811 BTC for $65.5 million at an average $80,846, taking holdings to 849,327 BTC, alongside $208 million of STRC repurchases and $164 million raised selling 1.18 million MSTR shares. Binance says it is working to resume withdrawals for additional networks with the next phase planned for Tuesday.

19 read in full, 200 items in the section

Feed

145 stories · 145 newCross-publisher stories only
  1. Pinned
  2. 145 new
  3. QQQM — Hold
    TradingView [COMMENT]
  4. NZD/CAD: Bearish Breakdown Tests April 2025 Lows
    TradingView [COMMENT]
  5. XAUUSD /GOLD
    TradingView [COMMENT]
  6. Needham raises Tempus AI stock price target to $89 on data growth
    Investing.com - news 2 itemsalso Investing.com - UK
  7. Publicis Groupe completes LiveRamp acquisition
    Investing.com - news 2 itemsalso Investing.com - UK
  8. Stylam Industries
    TradingView [COMMENT]
  9. Form 144 Ceribell For: 2 November
    Investing.com - UK 11 itemsalso Investing.com - UK
  10. Vertex faces earnings test as kidney drugs near key milestones
    Investing.com - news 2 itemsalso Investing.com - UK
  11. Shopify faces earnings test as AI shopping bet takes center stage
    Investing.com - UK 2 itemsalso Investing.com - news
  12. Amcor earnings up next: Can Berry synergies offset volume slide?
    Investing.com - UK 2 itemsalso Investing.com - news
  13. Williams faces earnings test as data center power push accelerates
    Investing.com - UK 2 itemsalso Investing.com - news
  14. Why is Check Point Software stock sliding today?
    Investing.com - UK 2 itemsalso Investing.com - news
  15. Expeditors International stock hits all-time high at 201.18 USD
    Investing.com - UK 10 itemsalso Investing.com - news
  16. Pfizer earnings on deck: Prevnar pressures test growth story
    Investing.com - UK 2 itemsalso Investing.com - news
  17. Bio-Techne faces earnings test ahead of Merck acquisition close
    Investing.com - UK 2 itemsalso Investing.com - news
  18. Diamondback Energy set to report Q3 earnings after strong Q2
    Investing.com - UK 2 itemsalso Investing.com - news
  19. It is my Great Honor to endorse America First Patriot, Michael Whatley, who is running for the United States Senate in the Great State of North Carolina, which I love and WON BIG, six times, including Primaries, in 2016, 2020, and 2024! Michael is fantastic at everything he does, and was certainly a STAR as Co-Chair of the RNC where, in the Presidential Election, we won every Swing State, the Popular Vote, and the Electoral College by a landslide. Michael is a wonderful man, and has ALWAYS delivered for North Carolina, especially after the terrible floods, where the Biden Administration did nothing. His opponent, Roy Cooper, is a Radical Left Dumocrat who is opposed to NO TAX ON TIPS, NO TAX ON OVERTIME, and NO TAX ON SOCIAL SECURITY and, if he and the Dumocrats ever got in, all of these things will be terminated. He wants massive Tax Increases, Open Borders, Men playing in Women's Sports, and Transgender Mutilization of your Children. Roy Cooper is Reckless, Radical, and Dangerous! On the other hand, as your next Senator, Michael will fight tirelessly to Grow our Economy, Cut Taxes and Regulations, Promote MADE IN THE U.S.A., Champion American Energy DOMINANCE, Keep our now very Secure Border, SECURE, Stop Migrant Crime, Strengthen our Incredible Military/Veterans, and Protect our always under siege Second Amendment. Michael Whatley has my Complete and Total Endorsement to be the next United States Senator from the Great State of North Carolina. GET OUT AND VOTE FOR MICHAEL — HE WILL NEVER LET YOU DOWN! President DONALD J. TRUMP
    Trump (Truth Social)
  20. XAUUSD H1
    TradingView [COMMENT]
  21. XAUUSD POTENTIAL BEARISH REVERSAL
    TradingView [COMMENT]
  22. Market update 02.11
    TradingView [COMMENT]
  23. Eaton earnings loom Tuesday after sharp selloff tests growth narrative
    Investing.com - UK 2 itemsalso Investing.com - news
  24. Baird cuts Bright Minds stock price target on clinical hold delay
    Investing.com - UK 2 itemsalso Investing.com - news
  25. Weekly Technical Analysis - 2 November 2026
    TradingView [COMMENT] 5 items
  26. Sahyadri Industries
    TradingView [COMMENT]
  27. Ex-Div Reminder for Brown & Brown (BRO)
    Nasdaq - stocks
  28. ORRF Ex-Dividend Reminder - 11/3/26
    Nasdaq - stocks
  29. December 2027 Options Now Available For Devon Energy (DVN)
    Nasdaq - stocks 3 itemsalso Nasdaq - stocks
  30. Interesting HUBB Put And Call Options For December 2027
    Nasdaq - stocks 2 itemsalso Nasdaq - stocks
  31. Ferrari in the spotlight: Can pricing power offset volume slide?
    Investing.com - news 2 itemsalso Investing.com - UK
  32. Academy Sports and Outdoors stock hits 52-week high at $62.45
    Investing.com - news 2 itemsalso Investing.com - UK
  33. Roku earnings in focus: Can advertising gains offset EPS slide?
    Investing.com - news 2 itemsalso Investing.com - UK
  34. Form 8K Oppenheimer Holdings Inc For: 2 November
    Investing.com - UK 34 itemsalso Investing.com - UK
  35. Choice Hotels Q3 2026 slides: franchisee focus drives turnaround
    Investing.com - news 2 itemsalso Investing.com - UK
  36. Fti Consulting stock hits 52-week high at 189.34 USD
    Investing.com - news 11 itemsalso Investing.com - UK
  37. Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.80%
    Investing.com - news 2 itemsalso Investing.com - UK
  38. Energy Transfer earnings loom as data center demand tests growth
    Investing.com - news 2 itemsalso Investing.com - UK
  39. SBA Communications faces earnings test amid industry shifts
    Investing.com - news 2 itemsalso Investing.com - UK
  40. Apollo Global earnings on deck as rate worries test alts sector
    Investing.com - news 2 itemsalso Investing.com - UK
  41. Upcoming Dividend Run For SXC?
    Nasdaq - stocks 2 itemsalso Nasdaq - stocks
  42. Viper Energy faces earnings test as analysts eye production
    Investing.com - news 2 itemsalso Investing.com - UK
  43. MPLX earnings in focus as distribution hikes clash with profit slide
    Investing.com - news 2 itemsalso Investing.com - UK
  44. Corebridge earnings up next: Can annuity boom lift revenue?
    Investing.com - news 2 itemsalso Investing.com - UK
  45. Ametek earnings on deck as $5B acquisition tests growth strategy
    Investing.com - news 2 itemsalso Investing.com - UK
  46. Neurocrine earnings in focus as Ingrezza pricing pressure looms
    Investing.com - news 2 itemsalso Investing.com - UK
  47. Coca-Cola Europacific earnings up next amid guidance watch
    Investing.com - news 2 itemsalso Investing.com - UK
  48. Gold oversold bounce back resistance at 4076
    TradingView [COMMENT]
  49. Crude Oil Ceiling: Where Wicks Go To Die
    TradingView [COMMENT]
  50. Equitable earnings on deck as Corebridge merger close nears
    Investing.com - news 2 itemsalso Investing.com - UK
  51. Keurig Dr Pepper earnings up next as split countdown begins
    Investing.com - news 2 itemsalso Investing.com - UK
  52. Why is Marriott International stock surging today?
    Investing.com - UK 16 itemsalso Investing.com - news
  53. Why is PubMatic stock rallying today?
    Investing.com - UK 24 itemsalso Investing.com - news
  54. insightful trading
    TradingView [COMMENT]
  55. TradeCityPro | Bitcoin Daily Analysis #391
    TradingView [COMMENT]
  56. Sysco faces earnings test as Restaurant Depot deal looms
    Investing.com - news 2 itemsalso Investing.com - UK
  57. Form 4 AIM ETF Products Trust For: 2 November
    Investing.com - UK 7 items
  58. OIL
    TradingView [COMMENT]
  59. CHFJPY - Sell Strategy
    TradingView [COMMENT]
  60. ADM earnings up next: Can raised guidance offset commodity headwinds?
    Investing.com - news 2 itemsalso Investing.com - UK
  61. Anthropic posts $17B third-quarter revenue as landmark AI debut nears
    Investing.com - news 2 itemsalso Investing.com - UK
  62. Fabrinet earnings on deck: Can AI optics demand revive stock?
    Investing.com - news 2 itemsalso Investing.com - UK
  63. USOIL BULLISH RETRACEMENT
    TradingView [COMMENT]
  64. Fortis earnings ahead: Utility unveils five-year capital plan
    Investing.com - news 2 itemsalso Investing.com - UK
  65. Biomarin earnings on deck: Amicus integration in focus
    Investing.com - news 2 itemsalso Investing.com - UK
  66. Clorox earnings ahead as analysts cut targets on growth concerns
    Investing.com - news 2 itemsalso Investing.com - UK
  67. Fiserv earnings on deck as turnaround efforts face test
    Investing.com - news 2 itemsalso Investing.com - UK
  68. Expeditors earnings up next: Can air freight offset ocean woes?
    Investing.com - news 2 itemsalso Investing.com - UK
  69. Match Group earnings in focus: Can Tinder turnaround gain traction?
    Investing.com - news 2 itemsalso Investing.com - UK
  70. BioNTech earnings up next: Can revenue rebound offset cancer setback?
    Investing.com - news 2 itemsalso Investing.com - UK
  71. Hinge Health set to report earnings: Can growth momentum hold?
    Investing.com - news 2 itemsalso Investing.com - UK
  72. $ena
    TradingView [COMMENT]
  73. IREN: An Important Trend Support Zone
    TradingView [COMMENT]
  74. Ryman Hospitality earnings in focus as cost pressures test margins
    Investing.com - news 2 itemsalso Investing.com - UK
  75. Why is Cardinal Energy stock sliding today?
    Investing.com - news 16 items
  76. SILVER VIEW(DAILY TF)
    TradingView [COMMENT] 2 items
  77. SharkNinja Stock Hits Record High On Fresh Buy Rating
    Investor's Business Daily